Skip to main content
OE

Okeiro (ex Predict4Health)

This startup develops AI-powered tools for transplant patient care and chronic disease management. Their products include Predigraft, a decision-making tool that provides allograft survival prognoses for transplanted patients, and Apilife, a telemonitoring platform for chronic patients. They also offer a digital biomarker technology for assessing kidney allograft survival in clinical trials.

Founded 2023283K+ followers
Updated 18 months ago

Funding

$11.1M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

FCRR
Funding rounds are not available yet.

Founders

Product

Problem

Managing transplant patient care and chronic diseases often involves complex decision-making and continuous monitoring, which can be challenging for clinicians and patients. Existing methods may lack the ability to provide personalized, data-driven insights for predicting outcomes and facilitating timely interventions.

Solution

Predict4Health offers AI-powered tools designed to improve patient outcomes and simplify clinician workflows in transplant care and chronic disease management. The Predigraft platform provides clinicians with allograft survival prognoses, enabling data-driven treatment decisions and personalized care plans. Apilife is a telemonitoring platform that connects chronic patients with their medical teams, facilitating remote monitoring, secure communication, and access to medical documents. The iBox technology, integrated into Predigraft, leverages advanced algorithms to predict graft survival, allowing for early identification of potential complications and proactive intervention.

Target Audience

The primary users include physicians, hospitals, and pharmaceutical companies involved in transplant patient care, chronic disease management, and clinical trials. Patients with chronic conditions or those who have undergone organ transplantation are also target users.

Features

  • Predigraft: A decision-making tool providing probabilities of rejection and allograft survival based on the iBox technology.
  • Apilife: A connected platform for remote patient monitoring, secure communication, and access to medical documents.
  • iBox Technology: Predictive algorithm for assessing long-term graft survival, enabling personalized treatment strategies.
  • Optical character recognition (OCR) technology for automated processing of lab results and medical reports.
  • Customizable alerting system based on clinical and biological values.
  • Integration with hospital IT systems through standardized connectors (FHIR, HPRIM, HL7).
  • Secure data storage and transfer compliant with HDS, HIPAA, ISO 27001, and GDPR regulations.
  • Support for various organ transplants, including kidney, lung, bowel, heart, and liver.
This profile is AI-generated and may contain inaccuracies.